The interaction of clozapine with the metachlorophenylpiperazine (mCPP) discriminative stimulus

Life Sciences

Volumn 58, Issue 24, 1996, Pages

  Fiorella, D ^a   Rabin, R A ^a   Winter, J C ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

5 HT2c; Clozapine; Drug induced stimulus control; MCPP

Indexed keywords

ANIMALIA;

(3 CHLOROPHENYL)PIPERAZINE; CLOZAPINE; FLUPHENAZINE; NEUROLEPTIC AGENT; PHOSPHATIDYLINOSITIDE; SEROTONIN 2C AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOROID PLEXUS; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; RAT; TURNOVER TIME;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DISCRIMINATION (PSYCHOLOGY); DRUG INTERACTIONS; FLUPHENAZINE; PIPERAZINES; RATS; RATS, INBRED F344; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN;

EID: 15844407271     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00223-8     Document Type: Article

References (20)

1. J.V. BRADY, R.D. HIENZ and N.A. ATOR, Drug. Dev. Res. 20 231-249 (1990).
2. A. BREIER, B. KIRKPATRICK and R.W. BUCHANAN, Biol. Psychiatry 34 492-494 (1993).
3. M.J. BERRIDGE, C.P. DOWNES and M.R. HANLEY, Biochem. J. 206 587-595 (1982).
4. L.D. CHAIT, E.H. UHLENHOTH and JOHANSON C.E., Psychopharmacology 86 307-312 (1985).
5. P.J. CONN and E. SANDERS-BUSH, J. Neurochem. 47 1754-1769 (1986).
6. D. FIORELLA, R.A. RABIN and J.C. WINTER, Psychopharmacology 119 222-230 (1995).
7. D. FIORELLA, S. HELSLEY, R.A. RABIN and J.C. WINTER, Psychopharmacology, in press (1995).
8. N. IQBAL, G.M. ASNIS, S. WETZLER, R.S. KAHN, S.R. KAY and H.M. VAN PRAAG, Biol. Psychiatry 30 770-778 (1991).
9. R.S. KAHN and S. WETZLER, Biol. Psychiatry 30 1139-1166 (1991).
10. R.S. KAHN, M. DAVIDSON, L.J. SIEVER, S. SEVY and K.L. DAVID, Biol. Psychiatry 35 909-912 (1994).
11. J. KANE, G. HONIGFELD, J. SINGER and H.Y. MELTZER, Arch. Gen. Psychiatry 45 221-223 (1993).
12. J.H. KRYSTAL, J.P. SEIBYL and L.H. PRICE, Arch. Gen. Psychiatry 50 624-634 (1993).
13. M. KUOPAMMAKI, E. PALVIMAKI E. SYVALAHTI and J. HIETALA, Eur. J. Pharmacol. 255 91-97 (1994).
14. J.A. LIEBERMAN, B.L. SALTZ, C.A. JOHNS, S. POLLACK, M. BORNSTEIN M. and J. KANE, Br. J. Psychiatry 158 503-510 (1991).
15. O.K. LOWRY, N.J. ROSEBROUGH, A.L. FARR and R.J. RANDALL, J. Biol. Chem. 193 265-275 (1951).
16. H.Y. MELTZER and V.S. FANG, Arch. Gen. Psychiatry 33 279-286 (1976).
17. S.J. O'DELL, G.J. La HOSTE, C.B. WIDMARK, R.M. SHAPIRO, S.G. POTKIN and J.F. MARSHALL, Synapse 6 146 (1990).
18. R.R. OWEN, R. GUTTERREZ-ESTETNOU and J. HSIAO, Arch. Gen. Psychiatry 50 636-644 (1993).
19. J.C. WINTER and R.A. RABIN, Pharmacol. Biochem. Behav. 45 221-223 (1993).
20. J.C. WINTER, NIDA Monograph #146, GC Lin and RA Glennon (Eds), 157-182, USGPO, Washington D.C. (1994)